← Back to Search

Extracellular Matrix Therapy

InnovaMatrix AC porcine placental ECM therapy for Foot Ulcer

N/A
Recruiting
Led By Thomas E Serena, MD
Research Sponsored by SerenaGroup, Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 weeks
Awards & highlights

Study Summary

This trial will study the safety and effectiveness of a weekly application of sterilized, porcine placental ECM as a treatment for chronic, non-healing diabetic foot ulcers.

Eligible Conditions
  • Foot Ulcer

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 12 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Wound Healing area using digital image
Secondary outcome measures
Adverse events
Percentage area reduction
Wound Closure
Other outcome measures
Bacterial burden assessment
Presence of protease levels

Trial Design

1Treatment groups
Experimental Treatment
Group I: InnovaMatrix AC porcine placental ECM therapyExperimental Treatment1 Intervention
Eligible subjects will be treated with a weekly application of sterilized, porcine placental ECM followed by standard of care wound therapy and offloading

Find a Location

Who is running the clinical trial?

SerenaGroup, Inc.Lead Sponsor
21 Previous Clinical Trials
1,782 Total Patients Enrolled
7 Trials studying Foot Ulcer
423 Patients Enrolled for Foot Ulcer
Thomas E Serena, MDPrincipal InvestigatorSerenaGroup, Inc.
3 Previous Clinical Trials
206 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there currently openings for volunteers in this clinical research?

"According to the clinicaltrials.gov webpage, this trial has been actively recruiting since October 6th 2022 and was last updated on January 6th 2023."

Answered by AI

How many participants is this experiment accommodating?

"Affirmative, the information hosted on clinicaltrials.gov indicates that this medical experiment is actively recruiting participants. This trial was first made available to the public on October 6th 2022 and has been modified most recently in January of 2023. 30 people are being sought from 5 different locations for this endeavor."

Answered by AI

In what locations has this trial been implemented?

"The Serena Group Buffalo Research Center in Buffalo, New york; the SerenaGroup Monroeville in Monroeville, Pennsylvania; and the SerenaGroup Austin Research Centre in Austin, Texas are all hosting this clinical trial. An additional 5 research centres will be included as well."

Answered by AI
~12 spots leftby Apr 2025